ArticleFrontiers in nephrology2022

Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.

T Van Meerhaeghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.